First UK operation to tackle heart failure with novel nerve-stimulating implant
This is the Cardiofit device. Credit: University of Leicester
Researchers at the University of Leicester have announced that the UK's first operation to tackle heart failure (HF) with a novel nerve-stimulating device will be performed today (Thursday August 23) at Glenfield Hospital.
The operation, which is part of a clinical trial called INOVATE-HF, could pave the way for a revolutionary treatment of a condition that scientists say has reached "epidemic proportions."
INOVATE HF is a global investigational study to determine the safety and efficacy of the CardioFit system, an implantable electrical stimulation device designed to improve heart function in patients with HF. The study will evaluate the system's ability to reduce hospitalization and death among patients with HF, while also exploring whether combined treatment with CardioFit and prescription drug therapy is more effective than drug therapy alone.
The National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit is the first site in the UK to enrol patients in INOVATE-HF. The study's principal investigator at the site, and also the UK chief investigator, is Dr. André Ng, senior lecturer in cardiology at the University of Leicester and consultant cardiologist at Glenfield Hospital who carried out the world's first remote heart procedure using a robotic arm alongside 3-D mapping in 2010.
"Our aim with the INOVATE-HF study is to assess CardioFit's safety as well as its potential to improve heart function in patients with HF, thereby improving their quality of life and survival," said Dr. Ng. "If the hypothesis is proven in the study results, this could transform heart failure treatment and would support the use of the innovative therapy over and above tablets for standard heart failure treatment."
Heart failure is a common condition in which the heart's pumping function is compromised, leading to a cascade of limiting symptoms and poor overall body function. HF is also associated with increased mortality from sudden death as a result of dangerous heart rhythm disturbances. The condition significantly impacts the NHS due to the level of treatment required and the increased incidence of death.
In patients with HF, the nervous system is out of balance. This imbalance leads to added stress on the heart and progressive deterioration of cardiovascular function. The CardioFit system is intended to restore balance by activating a specific part of the nervous system (called the "parasympathetic" nervous system) to reduce stress on the heart, thereby alleviating HF symptoms and reversing HF deterioration. It operates by stimulating the vagus nerve on the right side of the neck.
"This is a potentially ground-breaking treatment for desperate patients with HF, a serious condition that has increased over the past years in epidemic proportions," Dr. Ng said. "My University of Leicester research group has been studying the relationship between vagus nerve stimulation and heart function for almost 15 years. It is really exciting that there is finally an innovative form of treatment available that will allow us to investigate its potential use in heart failure."
Pre-clinical data suggest that vagus nerve stimulation for the treatment of heart failure improves the function of the heart and reverses negative changes to the body associated with the condition. Moreover, the safety and performance of the CardioFit have been validated in a 32-patient, multi-centre, pilot clinical study conducted in Germany, Italy, The Netherlands and Serbia. Study data showed that patients experienced significant improvements across key clinical measures, including left ventricular function and structure, heart rate variability, and resting heart rate. Patients also showed improvement in self-reported quality of life surveys and six-minute hall walk tests. The INOVATE-HF study will broaden the research of CardioFit by enrolling more than 600 patients at up to 80 centres worldwide. The study investigates patients diagnosed with HF, aged 18 and over, who are being treated with a combination of medicines, but continue to have symptoms such as shortness of breath and fatigue.
"The INOVATE-HF study is representative of the world-class research being conducted at the University of Leicester to deliver improved patient care in hospitals," said Dr. Ng. "It epitomises the essence of good translational scientific research, where a firm scientific basis in the university lab is now applied to the clinical condition of heart failure."
Professor Huon Gray, Interim National Clinical Director for Cardiovascular Disease said:
"We know that heart failure can have a devastating effect on people's lives, so any potential advance in its treatment is to be welcomed.
"Despite a 40 percent drop in the number of deaths from heart disease over the last decade, cardiovascular disease remains a major cause of death and disability, and heart failure is one of the areas where we need to do more to improve results for patients. We are committed to supporting any work which helps us achieve this, and we welcome all such innovative research."
The INOVATE-HF study team at the University of Leicester includes Matt Bown, senior lecturer in vascular surgery; Iain Squire, professor in cardiovascular medicine; Kieran Brack, BHF intermediate basic science research fellow and research coordinator for the trial; and other members of the University Hospitals of Leicester. The study is sponsored by BioControl Medical (Yehud, Israel), the developer of the CardioFit device.
Provided by University of Leicester
- ESC pilot registry in heart failure reflects improvement in chronic disease Aug 30, 2011 | not rated yet | 0
- Sexual health of men with chronic heart failure significantly improves with CRT Jun 02, 2011 | not rated yet | 0
- Heart failure linked to cognitive impairment Feb 05, 2009 | not rated yet | 0
- The effect of eplerenone vs. placebo on cardiovascular mortality Aug 29, 2011 | not rated yet | 0
- EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation May 22, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Solvability of a circuit
2 hours ago Let's say I have a circuit consisting only of a finite number of batteries and resistors, all ideal. Given an arbitrary shape of this circuit, will I...
Question about perception of colors around light sources
5 hours ago When I look at a distant light source (like car headlights, or street lamp lights) I notice colors of the visible spectrum (as separated (as in after...
Does a charged particle rotate when traveling through a static Bf?
7 hours ago I have been looking at mass spectrometers, in particular the interactions between the Bf ind of a charged particle in motion in a static Bf of the...
Find a link between physics and assignment problems
8 hours ago Hi ! I've been working about assignments problems and how to solve them. I will have to do a presentation about it in few weeks. However, I'll...
Light as a source of electricity
8 hours ago Hello Dear Fellows! We all know that light is an electromagnetic wave and also we know that an antenna receives EM waves and...
A question about the energy stored in a capacitor.
8 hours ago If we imagine a simple circuit with a battery and a capacitor with negligible internal resistance, the capacitor is charged up to a point where the...
- More from Physics Forums - Classical Physics
More news stories
(HealthDay)—Blood levels of free fatty acids are associated with insulin resistance during young adulthood and cardiovascular risk factors in later adulthood, according to a study published online May 13 ...
Cardiology May 17, 2013 | not rated yet | 0 |
An experimental, inexpensive iPhone application transmitted diagnostic heart images faster and more reliably than emailing photo images, according to a research study presented at the American Heart Association's Quality ...
Cardiology May 17, 2013 | not rated yet | 0
Extracorporeal membrane oxygenation (ECMO), a procedure traditionally used during cardiac surgeries and in the ICU that functions as an artificial replacement for a patient's heart and lungs, has also been used to resuscitate ...
Cardiology May 17, 2013 | not rated yet | 0
Age has little to do with how patients should be treated after suffering a stroke, according to new research from the University of Georgia.
Cardiology May 17, 2013 | not rated yet | 0 |
Depressed middle-aged women have almost double the risk of having a stroke, according to research published in Stroke: Journal of the American Heart Association.
Cardiology May 16, 2013 | not rated yet | 0
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
7 hours ago | not rated yet | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
8 hours ago | 5 / 5 (2) | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
8 hours ago | 5 / 5 (3) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
7 hours ago | 5 / 5 (1) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
12 hours ago | not rated yet | 0
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
7 hours ago | not rated yet | 0